F S van Dam
Overview
Explore the profile of F S van Dam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
900
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Dam F, van Maanen H
Ned Tijdschr Geneeskd
. 2004 Jun;
148(22):1077-8.
PMID: 15198059
Prismant, the major institute for health-care research in the Netherlands, presented differences in mortality data from hospitals in the Netherlands. The data from the Prismant study were front-page news. However,...
2.
van Dam F
Ned Tijdschr Geneeskd
. 2004 May;
148(17):814-5.
PMID: 15141645
For physicians and patients, knowledge of the treatment results of individual hospitals is of great importance as it is known that hospitals with more experience perform better. Oncological characteristics of...
3.
van Dam F
Ned Tijdschr Geneeskd
. 2004 Apr;
148(13):629-30.
PMID: 15083630
As a result of the illness and treatment of the Dutch comedian Sylvia Millecam, who died of the consequences of an untreated mammary carcinoma following a quest for help from...
4.
Puts M, Versloot J, Muller M, van Dam F
Ned Tijdschr Geneeskd
. 2004 Mar;
148(6):277-80.
PMID: 15004955
Objective: To study the care utilisation and unmet care needs of patients receiving palliative treatment at the day care clinic of the Netherlands Cancer Institute/Antoni van Leeuwenhoek hospital. Design: Descriptive....
5.
Renckens C, van Dam F
Ned Tijdschr Geneeskd
. 2004 Jan;
147(52):2607.
PMID: 14723043
No abstract available.
6.
van Dam F, Goudsmit M, Jonker T, Eeltink C, Muller M
Ned Tijdschr Geneeskd
. 2003 Oct;
147(36):1731-4.
PMID: 14520799
Objective: To determine the use of alternative diets and other alternative treatments in 2002 compared to 1999. Design: Descriptive, questionnaire. Method: During the period 13-26 May 2002 a survey was...
7.
Schagen S, Hamburger H, Muller M, Boogerd W, van Dam F
J Neurooncol
. 2001 Jun;
51(2):159-65.
PMID: 11386413
Objectives: To evaluate late neurotoxicity of adjuvant high-dose (HD) chemotherapy versus standard-dose (SD) chemotherapy by event-related potentials (ERP) and quantitative electroencephalography (qEEG). Patients And Methods: From a randomized study in...
8.
Renckens C, van Dam F, van der Smagt C
Ned Tijdschr Geneeskd
. 2001 Feb;
145(3):141-2.
PMID: 11206127
In May 1999 the Amsterdam Court of Justice decided that a retired internist and propagandist of his own alternative cancer therapy, could rightfully be called a quack by his critics....
9.
de Rond M, de Wit R, van Dam F, Muller M
J Pain Symptom Manage
. 2000 Dec;
20(6):424-39.
PMID: 11131261
Nurses need to be informed about the patient's pain to be able to take appropriate measures to alleviate pain. However, communication, assessment, and documentation of pain by nurses is often...
10.
van Dam F
Ned Tijdschr Geneeskd
. 2000 Sep;
144(37):1794-5.
PMID: 11004955
Some major cancer hospitals in the United States have established a department for complementary medicine as a service to their patients. Surveys in the Netherlands have shown that notably nursing...